• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Total number of collaborations and working groups in the quarter

Dictionary: NCTR encourages its employees to engage with scientists across FDA and other government agencies, industry, and academia in cooperative learning to strengthen the scientific foundations vital to developing sound regulatory policy and leveraging resources in order to promote the international standardization and global harmonization of regulatory science.

As working groups and collaborations are established, the more information (e.g., research, results, findings, protocols, etc.), can be shared and leveraged across NCTR's internal and external stakeholders and utilized to develop/enhance better research methods and tools. (1) (2)

Information is current as of December 31, 2013.

Fiscal Year - 2013

Skip graphic and jump to text data

Oct-Dec 2012N/A272
Jan–Mar 2013N/A271
Apr–Jun 2013N/A273
Jul-Sept 2013N/A282

FY 2013 Total: 1,098


  • (1) The FY10 Total is the total of data provided in FY 2010. Note that this may not include all 12 months due to data collection limitations when implementing FDA-TRACK.
  • (2) December 2009 data incorporates only the pilot division data, Division of Neurotoxicity.

Number of collaborative scientific working groups with a NCTR representative in the quarter

Fiscal Year - 2013
Skip graphic and jump to text data.

Oct-Dec 2012N/A180
Jan–Mar 2013N/A184
Apr–Jun 2013N/A187
Jul-Sept 2013N/A191

FY 2013 Total: 742

Number of presentations conducted with external stakeholders in the quarter

Fiscal Year - 2013
Skip graphic and jump to text data.

Oct-Dec 2012N/A67
Jan–Mar 2013N/A42
Apr–Jun 2013N/A57
Jul-Sept 2013N/A58

FY 2013 Total: 224


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.